Target Gene/Pathway Pathway / Gene
Search results
No. | KEGG PATHWAY On map, Yellow: Drug target, Red: All disease-related | KEGG GENES | KEGG DRUG | DrugBank | Disease ID |
---|---|---|---|---|---|
1 | Apoptosis 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
NGF [1] NGF 💬
|
Tanezumab Tanezumab 💬
| Tanezumab | 226 [2] 226, 298 💬
|
2 | Apoptosis - multiple species 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
NGFR [1] NGFR 💬
|
Cenegermin Cenegermin 💬
| Cenegermin | 053 [2] 53, 90 💬
|
3 | Calcium signaling pathway 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
NGF [1] NGF 💬
|
Tanezumab Tanezumab 💬
| Tanezumab | 226 [2] 226, 298 💬
|
4 | Cytokine-cytokine receptor interaction 💬 2 genes, 2 drugs (DrugBank) and 4 diseases |
NGF [1] NGF 💬
|
Tanezumab Tanezumab 💬
| Tanezumab | 226 [2] 226, 298 💬
|
5 | Cytokine-cytokine receptor interaction 💬 2 genes, 2 drugs (DrugBank) and 4 diseases |
NGFR [1] NGFR 💬
|
Cenegermin Cenegermin 💬
| Cenegermin | 053 [2] 53, 90 💬
|
6 | Inflammatory mediator regulation of TRP channels 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
NGF [1] NGF 💬
|
Tanezumab Tanezumab 💬
| Tanezumab | 226 [2] 226, 298 💬
|
7 | MAPK signaling pathway 💬 2 genes, 2 drugs (DrugBank) and 4 diseases |
NGF [1] NGF 💬
|
Tanezumab Tanezumab 💬
| Tanezumab | 226 [2] 226, 298 💬
|
8 | MAPK signaling pathway 💬 2 genes, 2 drugs (DrugBank) and 4 diseases |
NGFR [1] NGFR 💬
|
Cenegermin Cenegermin 💬
| Cenegermin | 053 [2] 53, 90 💬
|
9 | Neurotrophin signaling pathway 💬 2 genes, 2 drugs (DrugBank) and 4 diseases |
NGF [1] NGF 💬
|
Tanezumab Tanezumab 💬
| Tanezumab | 226 [2] 226, 298 💬
|
10 | Neurotrophin signaling pathway 💬 2 genes, 2 drugs (DrugBank) and 4 diseases |
NGFR [1] NGFR 💬
|
Cenegermin Cenegermin 💬
| Cenegermin | 053 [2] 53, 90 💬
|
11 | PI3K-Akt signaling pathway 💬 2 genes, 2 drugs (DrugBank) and 4 diseases |
NGF [1] NGF 💬
|
Tanezumab Tanezumab 💬
| Tanezumab | 226 [2] 226, 298 💬
|
12 | PI3K-Akt signaling pathway 💬 2 genes, 2 drugs (DrugBank) and 4 diseases |
NGFR [1] NGFR 💬
|
Cenegermin Cenegermin 💬
| Cenegermin | 053 [2] 53, 90 💬
|
13 | Rap1 signaling pathway 💬 2 genes, 2 drugs (DrugBank) and 4 diseases |
NGF [1] NGF 💬
|
Tanezumab Tanezumab 💬
| Tanezumab | 226 [2] 226, 298 💬
|
14 | Rap1 signaling pathway 💬 2 genes, 2 drugs (DrugBank) and 4 diseases |
NGFR [1] NGFR 💬
|
Cenegermin Cenegermin 💬
| Cenegermin | 053 [2] 53, 90 💬
|
15 | Ras signaling pathway 💬 2 genes, 2 drugs (DrugBank) and 4 diseases |
NGF [1] NGF 💬
|
Tanezumab Tanezumab 💬
| Tanezumab | 226 [2] 226, 298 💬
|
16 | Ras signaling pathway 💬 2 genes, 2 drugs (DrugBank) and 4 diseases |
NGFR [1] NGFR 💬
|
Cenegermin Cenegermin 💬
| Cenegermin | 053 [2] 53, 90 💬
|
17 | Transcriptional misregulation in cancer 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
NGFR [1] NGFR 💬
|
Cenegermin Cenegermin 💬
| Cenegermin | 053 [2] 53, 90 💬
|
18 | Virion - Lyssavirus 💬 1 gene, 1 drug (DrugBank) and 2 diseases |
NGFR [1] NGFR 💬
|
Cenegermin Cenegermin 💬
| Cenegermin | 053 [2] 53, 90 💬
|